Source:http://linkedlifedata.com/resource/pubmed/id/20729080
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
19
|
pubmed:dateCreated |
2010-9-13
|
pubmed:abstractText |
We screened 1434 small heterocyclic molecules and identified thirteen 2,3,6-trisubstituted quinoxaline derivatives that were able to inhibit the Wnt/?-catenin signal pathway and cell proliferation. In the screen, some of the hit compounds such as the ethylene group-coupled quinoxaline derivatives were shown to hold promise for use as potential small-molecule inhibitors of the Wnt/?-catenin signal pathway in non-small-cell lung cancer cell lines.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
1464-3405
|
pubmed:author | |
pubmed:copyrightInfo |
Copyright © 2010 Elsevier Ltd. All rights reserved.
|
pubmed:issnType |
Electronic
|
pubmed:day |
1
|
pubmed:volume |
20
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
5900-4
|
pubmed:meshHeading |
pubmed-meshheading:20729080-Antineoplastic Agents,
pubmed-meshheading:20729080-Carcinoma, Non-Small-Cell Lung,
pubmed-meshheading:20729080-Cell Line, Tumor,
pubmed-meshheading:20729080-Humans,
pubmed-meshheading:20729080-Lung Neoplasms,
pubmed-meshheading:20729080-Quinoxalines,
pubmed-meshheading:20729080-Signal Transduction,
pubmed-meshheading:20729080-Wnt Proteins,
pubmed-meshheading:20729080-beta Catenin
|
pubmed:year |
2010
|
pubmed:articleTitle |
Identification of 2,3,6-trisubstituted quinoxaline derivatives as a Wnt2/?-catenin pathway inhibitor in non-small-cell lung cancer cell lines.
|
pubmed:affiliation |
Graduate School of Biotechnology, Korea University, Seoul 136701, Republic of Korea.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|